Calixar announces a collaborative research agreement with Thermo Fisher Scientific on multiple membrane proteins of high relevance to drug discovery

April 5, 2019

Thermo Fisher will use its cutting edge expression systems to produce several difficult to express membrane protein targets. Calixar will then use its patented technology and expertise to solubilize, stabilize and structurally and functionally characterize these challenging targets of high medical relevance.

Share this post

Secure and boost
your discovery programs

Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.